Results 31 to 40 of about 3,265,867 (293)

Drug resistance with monitored adherence [PDF]

, 2013
Drug resistance can be defined as the failure of a drug to exert its expected effect on pharmacological biomarkers and is caused by pharmacogenetic, cellular or clinical factors.
Walter, Philipp Niklaus
core   +1 more source

Subgroup based on single antiplatelet therapy (SAPT) choice following dual antiplatelet therapy (DAPT) in the short DAPT arm.

, 2023
Subgroup based on single antiplatelet therapy (SAPT) choice following dual antiplatelet therapy (DAPT) in the short DAPT arm.
Kevin R. Bainey (11060747), Andrew Yan (2422876), Blair J. MacDonald (16920547), David Bewick (16920550), Ricky D. Turgeon (6411179), Guillaume Marquis-Gravel (4044482)   +5 more
core   +1 more source

Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

Cerebrovascular Diseases Extra, 2016
Background and Purpose: The optimal use of antiplatelet therapy for intracranial branch atheromatous disease (BAD) is not known. Methods: We conducted a prospective multicenter, single-group trial of 144 consecutive patients diagnosed with probable BAD ...
Teruo Kimura, Adam Tucker, Toshihide Sugimura, Toshitaka Seki, Shin Fukuda, Satoru Takeuchi, Shiro Miyata, Tsutomu Fujita, Akira Hashizume, Naoto Izumi, Kazutsune Kawasaki, Makoto Katsuno, Masaaki Hashimoto, Kazuhiro Sako   +13 more
doaj   +1 more source

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy [PDF]

, 2015
OBJECTIVES This study sought to compare rates of stent thrombosis and major adverse cardiac and cerebrovascular events (MACCE) (composite of death, myocardial infarction, or stroke) after coronary stenting with drug-eluting stents (DES) versus bare ...
Garratt, Kirk N., Kereiakes, Dean J, Gershlick, Anthony H., Mauri, Laura, Massaro, Joseph M, Simon, Daniel I., Kandzari, David E, Lee, David P., Darius, Harald, Trebacz, Jaroslaw, Gershlick, Anthony H, Meredith, Ian T, Massaro, Joseph M., Lee, David P, Cutlip, Donald E, Kandzari, David E., Kereiakes, Dean J., Meredith, Ian T., Windecker, Stephan, Iancu, Adrian Corneliu, Yeh, Robert W, Simon, Daniel I, Driscoll-Shempp, Priscilla, Steg, P Gabriel, Tanguay, Jean-François, Steg, P. Gabriel, Ormiston, John, Cutlip, Donald E., Garratt, Kirk N, Yeh, Robert W.   +29 more
core   +2 more sources

Vorapaxar as an Alternative for Ticagrelor Resistance in Neuroendovascular Intervention

Stroke: Vascular and Interventional Neurology, 2021
Background Perioperative dual‐antiplatelet therapy for flow diversion limits thromboembolic complications. However, resistance to dual‐antiplatelet therapy medications remains a concern for neuroendovascular intervention.
James C. Mamaril‐Davis, Pedro Aguilar‐Salinas, Leonardo B. Brasiliense, Richard Cosgrove, Judy Dawod, Travis M. Dumont, Mohammad El‐Ghanem   +6 more
doaj   +1 more source

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction [PDF]

, 2015
BACKGROUND The benefits and risks of prolonged dual antiplatelet therapy may be different for patients with acute myocardial infarction (MI) compared with more stable presentations.
Iancu, Adrian C, Windecker, Stephan, Kereiakes, Dean J, Gershlick, Anthony H., Yeh, Robert W, Mauri, Laura, Massaro, Joseph M, Steg, Philippe Gabriel, Gershlick, Anthony H, Cohen, David J., Massaro, Joseph M., Cohen, David J, Cutlip, Donald E, Wiviott, Stephen D., Iancu, Adrian C., Cutlip, Donald E., Rinaldi, Michael J, Tanguay, Jean-Francois, Jacobs, Alice, Wiviott, Stephen D, Kereiakes, Dean J., Yeh, Robert W., Rinaldi, Michael J.   +22 more
core   +2 more sources

Bleeding complications related to external ventricular drainage placement in patients with ruptured intracranial aneurysms: a single-center study

Frontiers in Surgery
ObjectiveAcute aneurysmal rupture can be treated with endovascular therapy or surgical clipping. For patients with concurrent acute hydrocephalus, the placement of an external ventricular drainage (EVD) is required.
Yue Tang, Xiangping Zhong, Tingting Lin, Fujun Zuo, Min Fu, Li Wang, Xiaodu Yu, Dong Liu, Jincan Zhang   +8 more
doaj   +1 more source

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations

European Cardiology Review, 2021
Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy. These special populations may warrant modification of
Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, Doreen Tan, Dmitry Duplyakov, Ayman Hammoudeh, Bo Zhang, Yi Li, Kai Xu, Paul J Ong, Doni Firman, Habib Gamra, Wael Almahmeed, Jamshed Dalal, Li-Wah Tam, Gabriel Steg, Quang N Nguyen, Junya Ako, Jassim Al Suwaidi, Mark Chan, Mohamed Sobhy, Abdulla Shehab, Wacin Buddhari, Zulu Wang, Alan Yean Yip Fong, Bilgehan Karadag, Byeong-Keuk Kim, Usman Baber, Chee Tang Chin, Ya Ling Han   +29 more
doaj   +1 more source

Assessing the optimal strategy for dual antiplatelet therapy [PDF]

Expert Review of Cardiovascular Therapy, 2015
Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Each year, millions of patients undergo stent placement to treat coronary artery disease. As stents are prone to thrombosis, which can potentially be devastating, patients are treated with dual antiplatelet therapy with aspirin plus a thienopyridine for at least 6-12 ...
Lee, Chang, Robert W, Yeh
openaire   +2 more sources

Cardiopulmonary resuscitation with assisted extracorporeal life support during cardiac arrest caused by drug-eluting stent thrombosis: a case report [PDF]

Korean Journal of Anesthesiology, 2014
Discontinuation of dual antiplatelet therapy within 12 months after drug-eluting stent (DES) implantation increases the possibility of stent thrombosis.
Ju-Hyun Lee, Sang-Heon Park, In Ae Song
doaj   +1 more source